CD274 and neoplasm: Factors that restrain the ability of LNs to generate an effective anti‐tumor immune response, such as a high density of PD‐1/PD‐L1 interaction[119, 122] and the presence of metastasized malignant cells,[66] correlate with patients’ response to ICB.